Literature DB >> 12141277

Olanzapine-induced galactorrhea.

Rasmus W Licht, Torben Arngrim, Hilmar Cristensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12141277     DOI： 10.1007/s00213-002-1067-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  9 in total

1.  Mirtazapine: an inhibitor of cortisol secretion that does not influence growth hormone and prolactin secretion.

Authors:  G Laakmann; C Schüle; T Baghai; E Waldvogel; M Bidlingmaier; C Strasburger
Journal:  J Clin Psychopharmacol       Date:  2000-02       Impact factor: 3.153

2.  Endocrine effects of lithium carbonate in healthy premenopausal women: relationship with body weight regulation.

Authors:  T Baptista; A Lacruz; S de Mendoza; M M Guillén; J L Burguera; M de Burguera; L Hernández
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2000-01       Impact factor: 5.067

3.  Olanzapine use in women with antipsychotic-induced hyperprolactinemia.

Authors:  C M Canuso; M Hanau; K K Jhamb; A I Green
Journal:  Am J Psychiatry       Date:  1998-10       Impact factor: 18.112

4.  Risperidone-induced galactorrhea.

Authors:  S Schreiber; R H Segman
Journal:  Psychopharmacology (Berl)       Date:  1997-04       Impact factor: 4.530

5.  The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations.

Authors:  A M Crawford; C M Beasley; G D Tollefson
Journal:  Schizophr Res       Date:  1997-07-25       Impact factor: 4.939

6.  Effects of short and long-term lithium treatment on serum prolactin levels in patients with bipolar affective disorder.

Authors:  M Baştürk; F Karaaslan; E Esel; S Sofuoğlu; A Tutuş; I Yabanoğlu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-02       Impact factor: 5.067

7.  Olanzapine serum concentrations in psychiatric patients given standard doses: the influence of comedication.

Authors:  O V Olesen; K Linnet
Journal:  Ther Drug Monit       Date:  1999-02       Impact factor: 3.681

Review 8.  Management of psychotropic-induced hyperprolactinemia.

Authors:  P A Marken; R F Haykal; J N Fisher
Journal:  Clin Pharm       Date:  1992-10

Review 9.  Prolactin and neuroleptic drugs.

Authors:  A I Green; W A Brown
Journal:  Neurol Clin       Date:  1988-02       Impact factor: 3.806
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.